CASI Pharmaceuticals Inc. (CASI)
(Delayed Data from NSDQ)
$2.42 USD
+0.12 (5.15%)
Updated Apr 26, 2024 10:10 AM ET
3-Hold of 5 3
C Value D Growth NA Momentum NA VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/15/24 |
---|---|
Current Quarter | -0.05 |
EPS Last Quarter | -0.29 |
Last EPS Surprise | -20.83% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.00 |
Next Year | 0.34 |
EPS (TTM) | -1.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.00M | 13.80M | 59.20M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 12.00M | 13.80M | 59.20M | NA |
Low Estimate | 12.00M | 13.80M | 59.20M | NA |
Year ago Sales | 8.35M | 9.82M | 33.04M | 59.20M |
Year over Year Growth Est. | 43.71% | 40.53% | 79.20% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.05 | -0.01 | 0.00 | 0.34 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.05 | -0.01 | 0.00 | 0.34 |
High Estimate | -0.05 | -0.01 | 0.00 | 0.34 |
Low Estimate | -0.05 | -0.01 | 0.00 | 0.34 |
Year ago EPS | -0.45 | -0.77 | -1.86 | 0.00 |
Year over Year Growth Est. | 88.89% | 98.70% | 100.00% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.05 | -0.01 | 0.00 | 0.34 |
7 Days Ago | -0.05 | -0.01 | 0.00 | 0.34 |
30 Days Ago | -0.05 | -0.01 | 0.00 | 0.34 |
60 Days Ago | -0.05 | -0.01 | 0.00 | 0.34 |
90 Days Ago | -0.05 | -0.01 | 0.00 | 0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.01 | 0.00 | 0.34 |
Zacks Consensus Estimate | -0.05 | -0.01 | 0.00 | 0.34 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.29 | -0.35 | -0.77 | -0.45 | NA |
Estimate | -0.24 | -0.56 | -0.50 | -0.64 | NA |
Difference | -0.05 | 0.21 | -0.27 | 0.19 | 0.02 |
Surprise | -20.83% | 37.50% | -54.00% | 29.69% | -1.91% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more